Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, COVID-19, Computerised tomogram thorax, Drug ineffective, SARS-CoV-2 test
Clinical narrative: had covid-19 symptoms last week/had tested positive to covid/had fever of 103, could not smell or taste/sent to wellness clinic where they only treat COVID patients; had covid-19 symptoms last week/had tested positive to covid/had fever of 103, could not smell or taste/sent to wellness clinic where they only treat COVID patients; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s): US-AMGEN-USASL2021181520.  A 60 year-old female patient received bnt162b2 (COVID-19 MANUFACTURER UNKNOWN), administration date Apr2021 (Batch/Lot number: unknown) at the age of 59 years as dose 2, single and administration date Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Rheumatoid arthritis" (ongoing). Concomitant medication(s) included: ENBREL taken from Nov2021 for rheumatoid arthritis; ELIQUIS; ASPIRIN; VITAMIN C [ASCORBIC ACID]; ELDERBERRY [SAMBUCUS NIGRA]; ZINC, INFLUENZA VACCINE on 27Oct2021. The patient believes she had COVID-19 symptoms last week/had tested positive to covid/had fever of 103, could not smell or taste/sent to wellness clinic where they only treat COVID patients, lingering headache, wake up with every morning and which is ongoing while receiving Enbrel with Single Dose Prefilled Autoinjector. The patient reported received first COVID vaccine on an unknown date in Mar2021 and then received second COVID vaccine on an unknown date in Apr2021, flu vaccine [The patient reported received flu vaccine 27OCT2021], Eliquis (apixaban), acetylsalicylic acid, vitamin c [ascorbic acid], Elderberry (sambucus nigra) and zinc. It was reported that, the patient had taken scheduled Enbrel dose on 27Oct2021 at night. On 29Oct2021, Friday, the patient had fever of 103, could not smell or taste. The patient had held Enbrel dose from an unknown date in Nov2021, the last two weeks. The patient went to doctor on 01NOV2021, Monday and had tested positive to covid on 01Nov2021. The patient was sent to wellness clinic where they only treat COVID patients and there the patient had a Chest CT (computerised tomogram) which was completely white and received an infusion (did not know name). The patient reported that, she was only a day away of being admitted to the hospital. However, the patient was sent home. The patient was asking if she should restart the Enbrel but was referred back to HCP (healthcare professional). The patient reported that, her primary HCP (healthcare professional) was aware of what happened and reported that HCP (healthcare professional) who prescribed the Enbrel was not aware. The patient reported that, she was feeling a whole lot better (as she was tested for covid). However, had a lingering headache that she wakes up with every morning and which was ongoing. The patient still could not taste some things, but that could take 2-3 months to come back. The patient could taste things that were salty, like they taste extremely salty; certain things that the patient could eat. The smell did come back. The patient experienced no fever and reported that last COVID test came back as negative. The following information was reported: COVID-19 (hospitalization, medically significant), DRUG INEFFECTIVE (hospitalization, medically significant) all with onset 29Oct2021, outcome "recovering" and all described as "had covid-19 symptoms last week/had tested positive to covid/had fever of 103, could not smell or taste/sent to wellness clinic where they only treat COVID patients". The event "had covid-19 symptoms last week/had tested positive to covid/had fever of 103, could not smell or taste/sent to wellness clinic where they only treat covid patients" and "had covid-19 symptoms last week/had tested positive to covid/had fever of 103, could not smell or taste/sent to wellness clinic where they only treat covid patients" was evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: computerised tomogram thorax: (01Nov2021) completely white; sars-cov-2 test: (01Nov2021) positive; (Nov2021) negative; body temperature: (29Oct2021) 103. Therapeutic measures were taken as a result of covid-19, drug ineffective. The causal relationship between the event suspected covid-19 was not provided by the consumer.   No follow-up attempts possible. No further information expected.